資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSELSEVIERIHS_EWB_GF

Global Thoracolumbar Spine Devices Market Research Report—Forecast till 2025

  • LinkedIn
  • facebook
  • Twitter
出版日期:2020/12/01
頁  數:156頁
文件格式:PDF
價  格:
USD 4,450 (Single-User License)
USD 6,250 (Global-User License)
線上訂購或諮詢
Global Thoracolumbar Spine Devices Market: Information by Product Type (Spinal implants, Devices and Instrumentation and Spine Biologics), By Type of Surgery (Open Surgery and Minimally Invasive Surgery (MIS)), by Material (Titanium, Stainless Steel, Biomaterials and others), By End User (Hospitals and Clinics, Ambulatory Surgery Centers, Academic Institutes and Research Centers and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

Market analysis
Generally, the increasing obese population, high prevalence of spinal cord injuries (SCI), and increasing geriatric population are expected to enhance market growth. Nevertheless, the stringent regulatory policies, lack of awareness for the use of advanced technologies, and product recalls are projected to curb the growth of the market. Thoracolumbar Spine Devices Market is expected to register a CAGR of 3.72% to reach USD 8,484.7 Million by 2025. Thoracolumbar junction is the junction between the thoracic spine and the lumbar spine. The junction involves of the part of the vertebral column from the eleventh thoracic vertebra to the first lumbar vertebra. Thoracolumbar spine devices are used in this region to deliver steady support to the spine and avert bending of the thoracic spine.

Market segmentation
The Global thoracolumbar spine devices market, by product type, has been segmented into spinal implants, devices and instrumentation and spine biologics respectively. Corresponding to a study published by the National Spinal Cord Injury Statistical Center in 2019, the annual incidence of SCI is approximately 54 per million people in the US or around 17,730 new cases each year. The approximate number of individuals affected by SCI in the US is 291,000. High prevalence of spinal cord injuries, in turn, increases the demand for thoracolumbar spine devices used in analysis. Thus, an increase in the prevalence of spinal cord injuries is expected to boost the global thoracolumbar spine devices market for the duration of the forecast period. The market is expected to witness a profitable growth owing to the high prevalence of spinal cord injuries (SCI). Based on the type of surgery, the thoracolumbar spine devices market has been categorized as open surgery and minimally invasive surgery (MIS). The material segment is further segmented as titanium, stainless steel, biomaterials, and others. Based on end-user, the thoracolumbar spine devices market has been grouped as hospitals and clinics, ambulatory surgery centers, academic institutions and research centers, and others.

Regional analysis
Geographically the Global thoracolumbar spine devices market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. Europe is anticipated to account for the second-largest market share during the forecast period. The market expansion in Europe can be attributed to the research and development by manufacturers for the launch of innovative products. For instance, ZygoFix Ltd, in 2018, initiated the first in a human clinical study for its clock spinal facet joint fixation system. Americas settled for the largest market share of in 2018, due to the presence of key market players, sophisticated healthcare infrastructure, and increasing R&D in the field of thoracolumbar spine devices. Asia-Pacific is likely to be the fastest-growing region in the global thoracolumbar spine devices market. The high growth rate is due to owing to the presence of a large patient base, availability of skilled healthcare personnel, and a defined regulatory framework facilitating enhanced product approvals. India held a share of 16.2% in the Asia-Pacific thoracolumbar spine devices market in 2018. The Middle East & Africa market is projected to show gradual growth during the forecast period. The Middle East would spearhead the market growth, attributing to facts such as the developing healthcare transportation, booming medical tourism, budding medical device industry, and gradually expanding adoption of medical analysis modalities in the Gulf Cooperation Council (GCC).

Major players
The proposed spectators in the Global thoracolumbar spine devices market are manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global thoracolumbar spine devices market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global thoracolumbar spine devices market are companies like Alphatech holdings, Inc. (US), B. Braun Melsungen AG (Germany), Depuy Synthes (US), Exactech, Inc. (US), Orthofix Holdings, Inc. (US), Globus Medical, Inc. (US), Medtronic PLC (Ireland), NuVasive, Inc. (US), Zimmer Biomet holdings, Inc. (US), Stryker corporation (US) and Globus Medical, Inc. (US),
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 16

1.2 KEY CONTRIBUTING FACTORS 17

1.3 MARKET ATTRACTIVENESS ANALYSIS 18

1.4 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY PRODUCT TYPE 19

1.5 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY TYPE OF SURGERY 20

1.6 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY MATERIAL 21

1.7 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY END USER 22

2 Market Introduction
2.1 DEFINITION 23

2.2 SCOPE OF THE STUDY 23

2.3 RESEARCH OBJECTIVE 23

2.4 MARKET STRUCTURE 24

2.5 ASSUMPTIONS & LIMITATIONS 24

3 Research Methodology
3.1 DATA MINING 25

3.2 SECONDARY RESEARCH 26

3.3 PRIMARY RESEARCH 27

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 28

3.5 FORECASTING TECHNIQUES 29

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 30

3.6.1 BOTTOM-UP APPROACH 31

3.6.2 TOP-DOWN APPROACH 31

3.7 DATA TRIANGULATION 32

3.8 VALIDATION 32

4 MARKET DYNAMICS
4.1 OVERVIEW 33

4.2 DRIVERS 34

4.2.1 INCREASING OBESE POPULATION 34

4.2.2 HIGH PREVALENCE OF SPINAL CORD INJURIES (SCI) 34

4.2.3 INCREASING GERIATRIC POPULATION 34

4.3 RESTRAINTS 35

4.3.1 STRINGENT REGULATORY POLICIES 35

4.3.2 LACK OF AWARENESS FOR THE USE OF ADVANCED TECHNOLOGIES 35

4.3.3 PRODUCT RECALLS 35

4.4 OPPORTUNITIES 36

4.4.1 LAUNCH OF INNOVATIVE PRODUCTS 36

5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 37

5.1.1 BARGAINING POWER OF SUPPLIERS 38

5.1.2 BARGAINING POWER OF BUYERS 38

5.1.3 THREAT OF NEW ENTRANTS 38

5.1.4 THREAT OF SUBSTITUTES 38

5.1.5 INTENSITY OF RIVALRY 38

5.2 VALUE CHAIN ANALYSIS 39

5.2.1 R&D AND DESIGNING 40

5.2.2 MANUFACTURING 40

5.2.3 DISTRIBUTION & SALES 40

5.2.4 POST-SALES REVIEW 40

5.3 INVESTMENT OPPORTUNITIES 41

6 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY PRODUCT TYPE
6.1 OVERVIEW 42

6.2 SPINAL IMPLANTS 44

6.3 DEVICES AND INSTRUMENTATION 44

6.4 SPINE BIOLOGICS 45

7 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY TYPE OF SURGERY
7.1 OVERVIEW 46

7.2 OPEN SURGERY 48

7.3 MINIMALLY INVASIVE SURGERY (MIS) 49

8 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY MATERIAL
8.1 OVERVIEW 50

8.2 TITANIUM 51

8.3 STAINLESS STEEL 52

8.4 BIOMATERIALS 53

8.5 OTHERS 53

9 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY END USER
9.1 OVERVIEW 54

9.2 HOSPITALS AND CLINICS 55

9.3 AMBULATORY SURGERY CENTERS 56

9.4 ACADEMIC INSTITUTES AND RESEARCH CENTERS 56

9.5 OTHERS 56

10 GLOBAL THORACOLUMBAR SPINE DEVICES MARKET, BY REGION
10.1 OVERVIEW 57

10.2 AMERICAS 59

10.2.1 NORTH AMERICA 61

10.2.2 LATIN AMERICA 66

10.3 EUROPE 68

10.3.1 WESTERN EUROPE 70

10.3.2 EASTERN EUROPE 80

10.4 ASIA-PACIFIC 82

10.4.1 JAPAN 84

10.4.2 CHINA 86

10.4.3 INDIA 87

10.4.4 SOUTH KOREA 88

10.4.5 AUSTRALIA 90

10.4.6 REST OF ASIA-PACIFIC 91

10.5 MIDDLE EAST & AFRICA 93

10.5.1 MIDDLE EAST 95

10.5.2 AFRICA 96

11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW 98

11.2 COMPANY RANKING 98

11.3 COMPETITIVE BENCHMARKING 100

11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE THORACOLUMBAR SPINE DEVICES MARKET 101

11.5 KEY DEVELOPMENT ANALYSIS 101

11.1 KEY DEVELOPMENTS & GROWTH STRATEGIES 102

11.1.1 NEW PRODUCT LAUNCH/APPROVAL 102

11.1.2 MERGERS & ACQUISITIONS 103

12 COMPANY PROFILES
12.1 ORTHOFIX HOLDINGS, INC. 104

12.1.1 COMPANY OVERVIEW 104

12.1.2 FINANCIAL OVERVIEW 105

12.1.3 PRODUCTS/SERVICES OFFERED 106

12.1.4 KEY DEVELOPMENTS 106

12.1.5 SWOT ANALYSIS 107

12.1.6 KEY STRATEGIES 107

12.2 ALPHATECH HOLDINGS, INC. 108

12.2.1 COMPANY OVERVIEW 108

12.2.2 FINANCIAL OVERVIEW 109

12.2.3 PRODUCTS/SERVICES OFFERED 109

12.2.4 KEY DEVELOPMENTS 110

12.2.5 SWOT ANALYSIS 110

12.2.6 KEY STRATEGIES 111

12.3 B. BRAUN MELSUNGEN AG 112

12.3.1 COMPANY OVERVIEW 112

12.3.2 FINANCIAL OVERVIEW 112

12.3.3 PRODUCTS/SERVICES OFFERED 113

12.3.4 KEY DEVELOPMENTS 113

12.3.5 SWOT ANALYSIS 114

12.3.6 KEY STRATEGIES 114

12.4 DEPUY SYNTHES 115

12.4.1 COMPANY OVERVIEW 115

12.4.2 FINANCIAL OVERVIEW 115

12.4.3 PRODUCTS/SERVICES OFFERED 116

12.4.4 KEY DEVELOPMENTS 116

12.4.5 SWOT ANALYSIS 117

12.4.6 KEY STRATEGIES 117

12.5 EXACTECH, INC. 118

12.5.1 COMPANY OVERVIEW 118

12.5.2 FINANCIAL OVERVIEW 118

12.5.3 PRODUCTS/SERVICES OFFERED 119

12.5.4 KEY DEVELOPMENTS 119

12.5.5 SWOT ANALYSIS 120

12.5.6 KEY STRATEGIES 120

12.6 GLOBUS MEDICAL, INC. 121

12.6.1 COMPANY OVERVIEW 121

12.6.2 FINANCIAL OVERVIEW 121

12.6.3 PRODUCTS/SERVICES OFFERED 122

12.6.4 KEY DEVELOPMENTS 122

12.6.5 SWOT ANALYSIS 123

12.6.6 KEY STRATEGIES 123

12.7 MEDTRONIC PLC 124

12.7.1 COMPANY OVERVIEW 124

12.7.2 FINANCIAL OVERVIEW 125

12.7.3 PRODUCTS/SERVICES OFFERED 125

12.7.4 KEY DEVELOPMENTS 126

12.7.5 SWOT ANALYSIS 126

12.7.6 KEY STRATEGIES 127

12.8 NUVASIVE, INC. 128

12.8.1 COMPANY OVERVIEW 128

12.8.2 FINANCIAL OVERVIEW 129

12.8.3 PRODUCTS/SERVICES OFFERED 129

12.8.4 KEY DEVELOPMENTS 130

12.8.5 SWOT ANALYSIS 130

12.8.6 KEY STRATEGIES 130

12.9 ZIMMER BIOMET HOLDINGS, INC. 131

12.9.1 COMPANY OVERVIEW 131

12.9.2 FINANCIAL OVERVIEW 132

12.9.3 PRODUCTS/SERVICES OFFERED 133

12.9.4 KEY DEVELOPMENTS 133

12.9.5 SWOT ANALYSIS 134

12.9.6 KEY STRATEGIES 134

12.10 STRYKER CORPORATION 135

12.10.1 COMPANY OVERVIEW 135

12.10.2 FINANCIAL OVERVIEW 136

12.10.3 PRODUCTS/SERVICES OFFERED 137

12.10.4 KEY DEVELOPMENTS 137

12.10.5 SWOT ANALYSIS 138

12.10.6 KEY STRATEGIES 138

13 APPENDIX
13.1 REFERENCES 139

13.2 RELATED REPORTS 139
回上頁